|
ZNF148 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.67730052069714E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.281799607739E-10 |
| Normal-vs-Stage2 |
1.67870000000736E-06 |
| Normal-vs-Stage3 |
7.66360308546155E-11 |
| Normal-vs-Stage4 |
1.71995750974929E-12 |
| Stage1-vs-Stage2 |
3.096200E-01 |
| Stage1-vs-Stage3 |
2.218600E-01 |
| Stage1-vs-Stage4 |
1.824950E-04 |
| Stage2-vs-Stage3 |
7.033800E-02 |
| Stage2-vs-Stage4 |
7.619200E-04 |
| Stage3-vs-Stage4 |
2.478100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.44789793674749E-11 |
| Normal-vs-AfricanAmerican |
8.180800E-04 |
| Normal-vs-Asian |
1.41130440667325E-11 |
| Caucasian-vs-AfricanAmerican |
1.345000E-01 |
| Caucasian-vs-Asian |
2.151400E-01 |
| AfricanAmerican-vs-Asian |
9.630000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.38249453288608E-11 |
| Normal-vs-Female |
3.96980004424563E-10 |
| Male-vs-Female |
2.858000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.83070036697109E-10 |
| Normal-vs-Age(41-60Yrs) |
3.89349996687827E-10 |
| Normal-vs-Age(61-80Yrs) |
4.38790004331224E-10 |
| Normal-vs-Age(81-100Yrs) |
2.583300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.416400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.049400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.762000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.445600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.913200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.840000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.599930E-03 |
| Classical-VS-Follicular |
2.067600E-01 |
| Classical-VS-Other |
2.909400E-01 |
| Classical-VS-Normal |
1.18020004880037E-09 |
| Tall-VS-Follicular |
6.046800E-04 |
| Tall-VS-Other |
8.508000E-01 |
| Tall-VS-Normal |
3.34987593220148E-12 |
| Follicular-VS-Other |
1.943200E-01 |
| Follicular-VS-Normal |
3.97649999595018E-08 |
| Other-VS-Normal |
9.181000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.06168415672892E-13 |
| Normal-vs-N1 |
4.83058038014406E-13 |
| N0-vs-N1 |
2.055700E-03 |
|
|
